USFDA has published the draft guidance for Review of Drug Master Files in Advance of Certain ANDA Submissions Under GDUFA. In certain instances, “DMF prior assessment,” could be requested for early assessment of Type II API DMFs 6 months prior to an ANDA or PAS submission referencing the DMF. Read More..